Sanjiv S. Agarwala, MD
Dr. Sanjiv Agarwala is chief of medical oncology and hematology at St. Luke‚Äôs Cancer Center in Bethlehem, PA, and professor of medicine at Temple University School of Medicine in Philadelphia. He is nationally and internationally recognized as an expert in the research and treatment of melanoma and cutaneous malignancies. He graduated from the University of Bombay and did residencies and fellowships at the University of Bombay in India, Dunedin University in New Zealand and University of Pittsburgh in Pittsburgh, PA. Dr. Agarwala has special interest and expertise in immunotherapy for cancer. He has been principal investigator for several clinical trials involving immunotherapy and targeted therapy for melanoma and other malignancies. He has written more than 100 publications and book chapters on melanoma and other research areas. He is board-certified in oncology, hematology and internal medicine, and is an active member of several professional and scientific societies, including the American Association for Cancer Research, the American Society of Clinical Oncology, the European Society of Medical Oncology and the Society for Melanoma Research.
"PVCT's PV-10 produced not only a local shrinkage of tumor, but also significant responses in noninjected lesions."
The Life Sciences Report Interview with Sanjiv Agarwala